





1078–5884/00Surgical Thrombectomy Followed by Intraoperative
Endovascular Reconstruction for Symptomatic Ilio-femoral
Venous Thrombosis
M.H.M. Schwarzbach,1* H. Schumacher,1* D. Bo¨ckler,1 S. Fu¨rstenberger,1
F. Thomas,1 R. Seelos,1 G.M. Richter2 and J.-R. Allenberg1Departments of 1Vascular and Endovascular Surgery, and 2Radiology, University of Heidelberg, Heidelberg,
GermanyObjectives. To evaluate the efficacy of surgical thrombectomy combined with endovascular reconstruction for acute ilio-
femoral/caval venous thrombosis.
Methods. Twenty consecutive patients with acute, symptomatic ilio-femoral/-caval thrombosis underwent valve-preserving
thrombectomy with immediate endovascular repair between October 1996 and October 2003. Thrombectomy was classified
by intraoperative venography as: TYPE IZcomplete, TYPE IIZpartial, TYPE IIIZcomplete with stenosis other than
thrombus, TYPE IVZpermanent occlusion. TYPEs I and IV were excluded from this analysis because endovascular repair
was not performed.
Results. Left-sided venous thrombosis predominated (90%). Lesions were located in the common iliac vein (85%), the
external iliac vein (10%), and the inferior vena cava (5%). Three TYPE II lesions and 17 TYPE III lesions (11 spurs, one
hypoplasia, one fibrosis, one haematoma, and three others) were diagnosed. Catheter-directed recanalisation (thrombecto-
my/thrombolysis) resolved TYPE II lesions in three patients. Balloon angioplasty (one patient), iliac stenting (15 patients
[two with thrombolysis]), and caval stenting (one patient) were employed in TYPE III stenoses. No serious complication or
death occurred. Mean follow-up was 21 months. Of 20 patients clinical results were excellent in 18 patients who maintained
patency of their reconstructed iliac veins. Primary and secondary patency rates were 80 and 90%, respectively.
Conclusions. Ilio-caval venous obstructions detected intraoperatively can be reconstructed in a one-stage combined
procedure. The specific endovascular approach depends on the type of residual venous obstruction. Excellent mid-term
results indicate that the proposed thrombectomy classification (TYPE I–IV) and treatment algorithm optimises the results in
selected patients with symptomatic venous thrombosis.Keywords: Venous stenting; Deep venous thrombosis; Iliac stenosis; Caval stenosis.Introduction
The standard recommended treatment for deep
venous thrombosis in the lower limb is to use heparin
anticoagulation in the initial phase. This is followed by
compression therapy and oral anticoagulants.1,2 The
aim is to prevent propagation of thrombus and
pulmonary embolism. Conservative treatment reduces
acute mortality and morbidity as well as recurrent
thrombosis.1,2
Surgical thrombectomymay be considered for acuteing author. Priv.-Doz.Dr.med. M. H. M. Schwarzbach,
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0058+ 09 $35.00/0 q 2004 Elsevier Ltd. All rights resersymptomatic venous thrombosis of the leg extending
into the iliac veins or vena cava (three- or four-level
venous thrombosis). Thrombectomy may be appro-
priate in patients with isolated pelvic or caval
thrombosis, floating thrombus, and pulmonary embo-
lism, and in acute limb ischaemia (venous gangrene,
phlegmasia cerulea dolens).3–8 The aim of surgery is
immediate relief of symptoms and prevention of
chronic venous insufficiency. It is appropriate in
certain clinical situations including young and active
patients, in women during pregnancy and after
delivery, in patients with traumatic or postoperative
thrombosis.3–5,8
Long-term patency rates following surgical throm-
bectomy in the iliac veins range from 54 to 84% as
assessed by phlebography.9–12 Thrombosis recurs after
thrombectomy or thrombectomy fails to achieveEur J Vasc Endovasc Surg 29, 58–66 (2005)
doi:10.1016/j.ejvs.2004.09.022, available online at http://www.sciencedirect.com onved.
Venous Endovascular Surgery 59recanalisation in a proportion of patients.13 Reocclu-
sion after thrombectomy in patients with residual iliac
or caval venous stenosis is reported to be as high as
72%.13 Therefore, venous thrombectomy needs to be
followed by routine intraoperative angiography or
alternative investigations (angioscopy or endovascu-
lar ultrasound) to detect which patients are at risk of
developing recurrent occlusive thrombus.13–15 Where
residual obstruction is detected endovascular recon-
struction (stenting, angioplasty or catheter-guided
recanalisation) should be urgently considered. Few
published studies report the outcome of combined
surgical thrombectomy and intraoperative endovas-
cular venous reconstruction.13,16–19 We have been
performing venous thrombectomy with intraoperative
completion phlebography and subsequent endovas-
cular reconstruction as a combined one-stage pro-
cedure since October 1996 at our institution and report
our consecutive clinical series.MethodsSelection of patients
Patients in whom venous thrombectomy was per-
formed and who were additionally treated by intrao-
perative endovascular techniques (catheter-controlled
recanalisation or lysis, angioplasty, with or without
stent deployment) between October 1996 and October
2003 are reported in this clinical series. The indications
for surgical thrombectomy were deep venous throm-
bosis of the lower extremity extending into the iliac
veins or the vena cava demonstrated by colour duplex
sonography, MR/CT imaging or phlebography.
Patients with a history of malignancy were treated
only if they were at risk of imminent limb loss
(phlegmasia cerulea dolens or venous gangrene) or
had treatable disease. Surgical intervention was only
considered for patients in whom the onset of clinical
symptoms of the deep venous thrombosis (clinical
thrombus age) was less than 7 days.Classification of venous ilio-caval stenosis
The results of surgical thrombectomy was assessed
intraoperatively by ascending phlebography. Surgical
thrombectomy clearing all thrombotic material was
defined as TYPE I. Residual thrombotic stenosis or
occlusion after surgical thrombectomy was referred to
as TYPE II. Venous wall obstructions other than
residual thrombus (e.g. spur, web, hypoplasia, infiltra-
tion and compression) were defined as TYPE III.Permanent venous occlusions of the ilio-femoral
junction with impairment of the venous inflow were
defined as TYPE IV.One-stage endovascular procedure
Thrombotic material from below the inguinal ligament
was evacuated via an incision in the femoral vein. We
used a valve-preserving technique involving manual
compression of the leg augmented by elastic bandages
[under 15 mmHg PEEP ventilation (positive end
expiratory pressure) and 308 chest elevation]. We
avoided retrograde insertion of a balloon catheter to
preserve valve function in the axial veins of the lower
limb.20 Venous thrombectomy in the iliac veins and
IVC was performed with a balloon catheter and tactile
feedback during withdrawal of thrombus gave the
first indication of residual iliac or caval stenosis.20,21
Ascending phlebography was then performed in all
patients to assess the iliac veins.14,15 If residual venous
obstruction was detected an appropriate endovascular
treatment was chosen, depending on the location,
morphology, and nature of the lesion. Wire-guided
thrombectomy alone or in conjunction with local
thrombolysis were used to manage residual thrombo-
tic venous stenosis (TYPE II). Local thrombolysis was
carried out using a pulse-spray catheter (multi-side-
hole) to inject urokinase (250,000–500,000 IU). Venous
hypoplasia, a web or spur causing central venous
outflow obstruction (TYPE III) was treated by stent
deployment. Stents were placed using an introducer
sheath guided through the venotomy and adminis-
tered using a Terumow guide-wire under the guidance
of a mobile digital subtraction angiography unit.
When positioning the stent in the iliac vein, care was
taken not to occlude the internal iliac vein or the
contralateral common iliac vein with the device
extending into the inferior vena cava. Temporary
arterio-venous fistulas were not routinely fashioned.
Perioperatively anticoagulation was achieved using a
full-dose regimen with intravenous unfractionated
heparin. After discharge from the hospital, patients
usually received oral anticoagulation (phenprocou-
mon) for 6–12 months and testing for thrombophilic
disorders was advised. The duration of oral antic-
oagulation was determined for each patient individu-
ally in cooperation with a medical specialist in
thrombophilic diseases.Study population
Forty consecutive patients underwent surgery for ilio-
femoral/-caval thrombosis. Ten patients had a patentEur J Vasc Endovasc Surg Vol 29, January 2005
Table 1. Summary of the lesions identified in our series of 20
patients treated by combined surgical thrombectomy and endo-
vascular interventions
† Obstruction of the common iliac vein
† Stenosis by spur or web 11
† Radiogenic/fibrotic stenosis 1
† Residual thrombotic stenosis 3
† Compressive prevertebral hematoma 1
† Compressive bladder carcinoma 1
M. H. M. Schwarzbach et al.60ilio-caval system after central thrombectomy using a
Forgarty catheter (TYPE I thrombectomy). Four
patients with thrombotic venous obstruction were
found to be unreconstructable (TYPE IV) because of
phlegmasia, venous interruption with consecutive
descending thrombosis, or occlusion of the iliofemoral
junction without sufficient venous influx. Six patients
were treated by open thrombectomy of the iliac
system. For the purpose of this analysis patients
presenting with TYPEs I and IV lesions and patients
receiving open thrombectomy were excluded. These
patients were not included in our further clinical series
because there was no indication to perform angio-
plasty or to place a stent.
Twenty patients (17 female patients and three male
patients; mean age, 37 years) underwent thrombect-
omy and were found to have residual stenoses of
TYPE II and III. Additional endovascular reconstruc-
tion was required in these patients. Ten of these
patients (50%) had suffered venous thrombosis after
immobilisation [postoperatively (nZ6), economy class
syndrome (nZ2), fracture (nZ1) and delivery (nZ1)].
Seven patients (35%) had a thrombophilic disorder
[factor-V-Leiden mutation (nZ2), protein-C deficiency
(nZ1), prothrombin gene mutation (nZ2), heparin-
induced thrombocytopaenia (nZ1) and homocystei-
naemia (nZ1)]. Benign tumours were diagnosed in
four patients (20%) (one pancreatic tumour, one cystic
adenoma of the ovary, and two patients with myoma-
tous enlargement of the uterus). One patient was
suffering from an advanced bladder carcinoma and
required surgical treatment for venous phlegmasia.
Another male patient had a history of curative surgery
and adjuvant radio- and chemotherapy for rectal
cancer. Prostatic cancer with bone metastasis was
detected postoperatively in one other patient. Primary
venous thrombosis was diagnosed in 75% of the
patients, 25% with recurrent acute deep venous
thrombosis.† Obstruction of the external iliac vein
† Segmental stenosis 2
† Obstruction of the inferior vena cava
†Hypoplasia 1Follow-up
Patients were seen regularly during the observation
period in our outpatient clinic. The standard follow-up
was at 6 weeks and 6 months postoperatively and
yearly, thereafter. Patients were asked about symp-
toms suggesting thrombotic recurrence, including
pain and discomfort. Patients were categorised
according to their CEAP clinical stage following
clinical examination. We assessed swelling (measure-
ment) and visible venous disease including the
presence of reticular veins, varicose veins, ulceration
and skin changes. Clinical examinations were usuallyEur J Vasc Endovasc Surg Vol 29, January 2005combined with colour duplex sonography in order to
evaluate the patency of the venous reconstruction.
Further phlebography or MR angiography was not
performed to assess the outcome of treatment since we
considered duplex ultrasonography sufficient to
assess the patency of the iliac veins.ResultsConcomitant venous obstruction
Left-sided venous thrombosis predominated (90%).
Obstruction of the common iliac vein was observed in
17 of 20 patients (85%). Stenosis of the common iliac
vein was caused by residual thrombotic material
(TYPE II) in three patients (15%). Stenosis of the
common iliac vein was caused by a spur or web in 11
patients (55%) (TYPE III). One patient presented with a
fibrotic stenosis of the common iliac vein 3 years after
surgery and radiotherapy for curative treatment of a
rectal carcinoma (5%). A compressive obstruction of
the common iliac vein was caused by a prevertebral
haematoma after an orthopaedic operation to the spine
and in a further case by local spread of a bladder
tumour (patient with imminent venous gangrene)
(10%). Two patients were diagnosed with segmental
stenosis of the external iliac vein (10%) and one patient
with hypoplasia of the inferior vena cava (5%) (Table 1).Endovascular venous reconstruction
Endovascular repair of the venous obstructions
depended on the type and localisation of the stenosis.
Three patients with residual thrombus (TYPE II) in the
common iliac vein were treated by Terumow-guided
thrombectomy alone (nZ1) or in combination with
local thrombolysis (nZ2) (Fig. 1). Segmental stenoses
of the common iliac vein caused by venous spurs or
Fig. 1.A 43-year-old woman withMEN syndrome suffered an ilio-femoral thrombosis 3 days after pancreatic resection. After
clearing fresh thrombotic material venography showed residual thrombotic occlusion of the common iliac vein with
collateral venous drainage (TYPE II thrombectomy) (A). Using a Terumow guide wire the thrombus was passed under
radiographic control (B) and completely extracted by a wire-guided balloon catheter (C). Oral anticoagulation was continued
for 6 months. Duplex ultrasonography showed that the iliac veins were patent 23 months later.
Fig. 2. A 36-year-old woman with thrombosis extending from the thigh to the inferior vena cava 10 days after delivery.
Primary transfemoral central thrombectomy was complicated by rethrombosis. Following re-thrombectomy venography
showed an occlusion of the common iliac vein with collateral drainage (TYPE II thrombectomy) (A). Terumow-guided
thrombectomy (TYPE III thrombectomy) was combined with deployment of a Smartw stent to treat an iliac spur (B). After
stenting the iliac veins were patent (C). Postoperatively a heparin-induced thrombocytopenia type II was diagnosed. Clinical
symptoms resolved and the reconstruction was patent 3 months postoperatively.
Fig. 3. A 62-year-old man underwent transfemoral thrombectomy with subsequent ascending venography. The venous
angiogram shows a stenosis of the external iliac vein (TYPE III thrombectomy) (A). The stenosis was treated by deployment
of a Palmaz XXLw stent (B) and the reconstruction was patent on completion phlebography (C). Fifteen months after
treatment the reconstruction was patent and the patient was free of swelling and pain.
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Fig. 4. A 16-year-old female patient underwent transfemoral thrombectomy with subsequent ascending venography. The
venous angiogram showed segmental hypoplasia of the inferior vena cava (A) with collateral venous drainage (TYPE III).
The caval stenosis was treated by deployment of a Corinthianw stent resulting a patent IVC (B). One year after treatment the
patient was completely free of discomfort, swelling, and pain. Follow-up CT imaging showed the stent location (C) and
ultrasound confirmed a patent ilio-caval venous system (D).
M. H. M. Schwarzbach et al.62radiogenic fibrosis was treated by stent deployment
(13 patients with two patients receiving intraoperative
local thrombolysis) (TYPE III) (Fig. 2). Segmental
stenosis in the proximal region of the external iliac
vein was treated by balloon dilatation (one patient)
and by stenting (one patient) (Fig. 3). A 16-year-old girl
with a bilateral symptomatic thrombosis with massive
limb oedema and pain had caval hypoplasia and was
treated by stent deployment to the inferior vena cava
(Fig. 4). Two patients were treated by percutaneous
stent deployment. A total of 20 venous stents were
placed in the iliac veins. Balloon-expanded Palmazw
XXL stents (Cordis, Johnson and Johnson, USA) were
used to treat nine patients (12 stents). Self-expanding
Easy-Wallstentw endoprotheses (Boston Scientific,
USA) were used in four patients (six devices). The
Wallstentsw required dilatation after insertion because
of incomplete opening due to the fibrotic nature ofEur J Vasc Endovasc Surg Vol 29, January 2005pelvic spurs. Three patients were treated either with a
Symphonyw or a Smart stentw (Cordis, Johnson and
Johnson, USA). One Corinthianw stent (Cordis, John-
son and Johnson, USA) was deployed to treat the
stenosis of the inferior vena cava. Five of 16 patients
required placement of two stent devices. The stent
diameter in the common iliac vein was either 14 or
16 mm and the length 40 or 50 mm. Only one patient
with radiogenic stenosis of the common iliac vein was
treated by a stent of 12 mm in diameter.Feasibility and complications
Endovascular reconstruction was accomplished in all
patients without specific complications. One stent
(Palmaz XXLw) was dislodged into the inferior vena
cava by the introducer sheath during deployment of a
Venous Endovascular Surgery 63second stent. This was corrected by retraction and
repositioning with a balloon catheter. The local
morbidity (10%) consisted of one lymphatic fistula
and one seroma. No patient suffered clinically appar-
ent pulmonary embolism. No death occurred due to
surgery.Clinical outcome
The mean follow-up was 21 months (range, 0.5–77
months). Two patients died during the follow-up
period. At the most recent assessment the clinical
outcome was as follows:
CEAP clinical stageC0a: 13 patients (no visible venous disease,
asymptomatic),C1a: one patient (telangiectases and reticular veins),
C3a: four patients (oedema, asymptomatic), and
C3s: two patients (oedema, symptomatic with pain).Limb pain and clinically apparent swelling was
always associated with reocclusion of the iliac venous
outflow tract.
The primary patency rate of the central venous
reconstructions was 80% (16 of 20 patients). The
secondary patency rate was 90% (18 of 20 patients).
One early rethrombosis occurred in a 33-year-old
woman 10 days after thrombectomy and iliac stenting
(two Palmazw XXL stents) during the start of oral
anticoagulation. This patient had a postoperative deep
venous thrombosis of the iliac vein extending into the
vena cava associated with prothrombin gene
mutation. The rethrombosis was treated by intrave-
nous unfractionated heparin and resolved completely
as documented by CT scanning and duplex ultrasono-
graphy. Oral anticoagulation was continued for 1 year.
Clinically the patient presented without significant
swelling, pain and discomfort during follow-up. The
second early rethrombosis was observed in a 32-year-
old womanwith a cauda equina syndrome 3 days after
iliac stenting. A postoperative prevertebral haema-
toma after lumbar decompression caused thrombosis
as a result of compression of the external and common
iliac veins. The endovascular treatment consisted of
thrombolysis and deployment of two Wallstentsw for
the extended venous stenosis. Under conservative
treatment (compression and oral anticoagulation) the
iliac vein recanalised with minor clinical symptoms
(moderate swelling). Two patients experienced per-
sistent rethrombosis of the iliac venous tract with
development of a collateral venous circulation and
significant clinical symptoms. One of these patients, a47-year-old woman experienced rethrombosis after
incomplete recanalisation of the common iliac vein
by thrombectomy and additional catheter-directed
thrombolysis documented on completion venography.
Oral anticoagulation and compression therapy were
continued but an occluded iliac venous outflow tract
was diagnosed 6 months postoperatively. Another 31-
year-old woman who was treated for a third occur-
rence of a venous thrombosis and multiple episodes of
pulmonary embolism experienced rethrombosis of the
iliac veins 6 months after iliac stenting. A concomitant
protein C deficiency was diagnosed. The last two
patients experienced persistent swelling and pain in
the affected limb.Discussion
The outcome of venous thrombectomy depends on
whether iliac or caval obstruction is present as the
cause of the original thrombosis. A number of
mechanisms have been proposed. Valve-like strictures
of the left iliac vein causing ilio-femoral venous
thrombosis have been described.22,23 In 1956, May
and Thurner hypothesised that the pulsation of the
overlying right common iliac artery might induce
reactive cell proliferation in the venous wall of the left
iliac vein, giving rise to venous stenosis (web or
spur).24 The frequency of venous spurs in the left iliac
vein has been evaluated in autopsy studies and is
reported to be about 20%.25 In our series iliac stenoses
were also caused by a prevertebral haematoma,
retroperitoneal radiogenic fibrosis and tumour spread.
A recent analysis showed that 30 of 61 patients (49%)
with left-sided deep venous thrombosis presented
with a common iliac venous obstruction suggestive of
venous spurs.13 In the latter study, 16 of a total of 22
patients (73%) with such iliac venous obstructions
developed another thrombosis after venous throm-
bectomy without immediate stenting although antic-
oagulants were administered.
A number of surgical techniques have been advo-
cated to address venous spurs. Among these are
sapheno-femoral or ilio-iliac crossover bypasses, arter-
ial repositioning, peritoneal flap, fascia lata sling,
prosthetic bridging, and aortic elevation.13 Modern
endovascular techniques allow minimally invasive
reconstruction of the ilio-caval venous system. Follow-
ing thrombectomy any residual stenosis in this region
can be addressed by balloon angioplasty and stent-
ing.13,16–19 After central venous thrombectomy using
Fogarty catheters an ascending venography can be used
to detect such residual stenoses.14,15,21 We prefer wire-
guided thrombectomy as the endovascular procedureEur J Vasc Endovasc Surg Vol 29, January 2005
Table 2. The authors’ algorithm for the use of intraoperative endovascular reconstruction of the ilio-caval thrombosis included a
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require additional catheter-guided thrombolysis. Iliac
webs or spurs are effectively resolved by intraoperative
endovascular stenting or dilatation.13,16–19
We have suggested above a four stage classification
which describes the outcome of surgical thrombect-
omy as assessed by completion venography.15,16 Those
patients with a TYPE I outcome (complete recanalisa-
tion) require no additional treatment. Patients with
residual thrombus (TYPE II) benefit from catheter
thrombectomy combined in some cases with throm-
bolysis. Those with a TYPE III outcome will benefit
from dilatation and stenting of the residual stenosis.
Patients with a permanent occlusion of the iliofemoral
axis (venous interruption by trauma or other causes or
previous thrombotic occlusion) combined with an
insufficient venous inflow (TYPE IV) will not benefit
from intraoperative intervention of this type. Half of
our series belonged to TYPEs I and IV and therefore,
did not require additional treatment to the iliac veins.
We have summarised our algorithm in Table 2.
In this study, additional endovascular reconstruc-
tion was performed without serious complication. No
patient suffered clinically apparent pulmonary embo-
lism nor was any hospital mortality encounteredEur J Vasc Endovasc Surg Vol 29, January 2005despite the fact that temporary caval protection
devices (filters) were not routinely used, as has been
suggested by others.26–29 The primary and secondary
success rates of thrombectomy combined with endo-
vascular surgery were 80 and 90%, respectively. The
clinical outcome during the follow-up period was
excellent, although we acknowledge that this is based
on limited numbers. Our analysis was based on
observation of a clinical series assessed only by duplex
ultrasonography which we acknowledge may provide
less information than follow-up phlebography. How-
ever, we have reported a larger group than previous
publications in this field. (Table 3). Mickley et al.
observed a patency rate of 87% in eight patients with
acute ilio-femoral thrombosis after thrombectomy and
stenting.13 Respectable results were found in six
patients treated intraoperatively by stenting and AV-
fistulas during a follow-up period of 23.5 months.16
Apart from two case studies about intraoperative
endovascular venous reconstruction, another group
described the treatment of four patients after surgical
thrombectomy and percutaneous endovascular recon-
struction with patent reconstructions in all cases.17–19
In another series, satisfactory long-term success rates
have been described after surgical thrombectomy,
Table 3. Published clinical series using transfemoral surgical thrombectomy and intraoperative endovascular venous angioplasty in
patients with acute ilio-caval venous thrombosis
Author Year Number of patients Procedure Follow-up (months) Results




Mickley et al.13 1998 8 Thrombectomy,
stent placement
82% Patent




Lacroix et al.18 1998 1 Thrombectomy,
stent placement
24 Patent
Binkert et al.19 1998 4 Thrombectomy,
stent placement*
36 All patent
* Endovascular reconstruction was performed postoperatively.
Venous Endovascular Surgery 65angioscopy and selective stenting for benign venous
stenosis in the pelvis.30
In contrast to these small series, interventional
percutaneuos catheter-directed thrombolysis and
selective stenting was evaluated in a study from a
multi-centre registry.31 In the latter analysis a sub-
stantial number of major bleeding complications and a
low percentage of complete recanalisations was
observed.32,33 This series included patients with
chronic obstruction of the iliocaval-veins which may
be less suitable for endovascular repair. Several clinical
trials have shown that balloon angioplasty and stent
insertion for non-malignant venous ilio-caval obstruc-
tion is a promising technique.34–38 Our clinical data
suggest that prospective clinical trials should be
undertaken to address the question of the beneficial
effects of thrombectomy combined with endovascular
reconstruction in selected patients with acute sympto-
matic deep venous thrombosis.References
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